Trial intelligence / Profile preview

HT-0712 in Age-Associated Memory Impairment

NCT02013310Phase 2Completed

Sponsor
Dart NeuroScience LLC
Start
Dec 2013
Primary completion
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of HT-0712 in Age-associated memory impairment (AAMI), sponsored by Dart NeuroScience LLC. Started Dec 2013; status: completed.

02

Drugs

HT-0712
03

Conditions

Age-associated memory impairment (AAMI)

Beyond the preview

Go deeper on NCT02013310.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02013310.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call